ResMed (RMD) Tops Q3 EPS by 9c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $221.05 --0%
EPS Growth %: +5.5%
Financial Fact:
Research and development: 34.45M
Today's EPS Names:
SUNB, CULP, KFY, More
EPS Growth %: +5.5%
Financial Fact:
Research and development: 34.45M
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q3 EPS of $1.68, $0.09 better than the analyst estimate of $1.59. Revenue for the quarter came in at $1.12 billion versus the consensus estimate of $1.05 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oddity Tech Ltd. (ODD) Tops Q2 EPS by 1c
- How big a risk are rates to the AI boom?
- Boston Properties Inc. (BXP) PT Raised to $68 at Truist Securities
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
